115 related articles for article (PubMed ID: 31770603)
1. The impact of serum protein binding on bacterial killing of minocycline.
Xie LX; Zhou J; Ledesma KR; Merlau PR; Tam VH
J Glob Antimicrob Resist; 2020 Jun; 21():252-254. PubMed ID: 31770603
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Neutropenic Murine Pneumonia Model.
Zhou J; Ledesma KR; Chang KT; Abodakpi H; Gao S; Tam VH
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264853
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates.
Ricciardi R; Ricciardi AM; Danzi G
Infez Med; 2009 Dec; 17(4):236-9. PubMed ID: 20046104
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
Scheetz MH; Qi C; Warren JR; Postelnick MJ; Zembower T; Obias A; Noskin GA
Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline.
Alou L; Giménez MJ; Cafini F; Aguilar L; Sevillano D; González N; Torrico M; Prieto J; García-Rey C; García-Escribano N
J Antimicrob Chemother; 2009 Dec; 64(6):1230-3. PubMed ID: 19837715
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
[TBL] [Abstract][Full Text] [Related]
7. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
Tan TY; Ng LS; Tan E; Huang G
J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
[TBL] [Abstract][Full Text] [Related]
8. The complexity of minocycline serum protein binding.
Zhou J; Tran BT; Tam VH
J Antimicrob Chemother; 2017 Jun; 72(6):1632-1634. PubMed ID: 28333250
[TBL] [Abstract][Full Text] [Related]
9. Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens.
Dillon N; Holland M; Tsunemoto H; Hancock B; Cornax I; Pogliano J; Sakoulas G; Nizet V
EBioMedicine; 2019 Aug; 46():193-201. PubMed ID: 31353294
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.
Wang P; Bowler SL; Kantz SF; Mettus RT; Guo Y; McElheny CL; Doi Y
J Clin Microbiol; 2016 Dec; 54(12):2937-2941. PubMed ID: 27629901
[TBL] [Abstract][Full Text] [Related]
11. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.
Castanheira M; Mendes RE; Jones RN
Clin Infect Dis; 2014 Dec; 59 Suppl 6():S367-73. PubMed ID: 25371512
[TBL] [Abstract][Full Text] [Related]
12. In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.
Ku NS; Lee SH; Lim YS; Choi H; Ahn JY; Jeong SJ; Shin SJ; Choi JY; Choi YH; Yeom JS; Yong D; Song YG; Kim JM
Sci Rep; 2019 Nov; 9(1):17127. PubMed ID: 31748527
[TBL] [Abstract][Full Text] [Related]
13. Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.
Liang W; Liu XF; Huang J; Zhu DM; Li J; Zhang J
BMC Infect Dis; 2011 Apr; 11():109. PubMed ID: 21521536
[TBL] [Abstract][Full Text] [Related]
14. Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an
Beganovic M; Daffinee KE; Luther MK; LaPlante KL
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318006
[No Abstract] [Full Text] [Related]
15. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS
J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection.
Alfouzan WA; Noel AR; Bowker KE; Attwood MLG; Tomaselli SG; MacGowan AP
Int J Antimicrob Agents; 2017 Dec; 50(6):715-717. PubMed ID: 28705678
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of minocycline alone or in combination in multidrug-resistant Acinetobacter baumannii isolates.
Rodríguez CH; Nastro M; Vay C; Famiglietti A
J Med Microbiol; 2015 Oct; 64(10):1196-1200. PubMed ID: 26238719
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
Rao GG; Ly NS; Diep J; Forrest A; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2016 Sep; 48(3):331-6. PubMed ID: 27449542
[TBL] [Abstract][Full Text] [Related]
19.
Flamm RK; Shortridge D; Castanheira M; Sader HS; Pfaller MA
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427295
[TBL] [Abstract][Full Text] [Related]
20. Semi-mechanistic PK/PD modelling of combined polymyxin B and minocycline against a polymyxin-resistant strain of Acinetobacter baumannii.
Aranzana-Climent V; Buyck JM; Smani Y; Pachón-Diaz J; Marchand S; Couet W; Grégoire N
Clin Microbiol Infect; 2020 Sep; 26(9):1254.e9-1254.e15. PubMed ID: 32006693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
